NEOLEUKIN THERAPEUTICS INC (NLTX) Forecast, Price Target & Analyst Ratings

NASDAQ:NLTX • US64049K2033

Current stock price

3.49 USD
+0.05 (+1.45%)
At close:
3.42 USD
-0.07 (-2.01%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEOLEUKIN THERAPEUTICS INC (NLTX).

Forecast Snapshot

Consensus Price Target

Price Target
$1.53
-56.16% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 18, 2024
Period
Q4 / 2023
EPS Estimate
-$0.03
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.53
Upside
-56.16%
From current price of $3.49 to mean target of $1.53, Based on 6 analyst forecasts
Low
$1.52
Median
$1.53
High
$1.58

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for NLTX. The average price target is 1.53 USD. This implies a price decrease of -56.16% is expected in the next year compared to the current price of 3.49.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NLTX Current Analyst RatingNLTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

NLTX Historical Analyst RatingsNLTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
NLTX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NLTX.
In the previous month the buy percentage consensus was at a similar level.
NLTX was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-05-09MizuhoMaintains Neutral
2023-01-03GuggenheimDowngrade Buy -> Neutral
2022-11-16HC Wainwright & Co.Downgrade Buy -> Neutral
2022-11-15MizuhoDowngrade Buy -> Neutral
2022-11-15GuggenheimDowngrade Buy -> Neutral
2022-11-15StifelDowngrade Buy -> Hold
2022-11-15Canaccord GenuityDowngrade Buy -> Hold
2022-09-12B of A SecuritiesDowngrade Buy -> Underperform
2022-09-12HC Wainwright & Co.Maintains Buy
2022-03-02Piper SandlerMaintains Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 18, 2024
Period
Q4 / 2023
EPS Estimate
-$0.03
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
97.45%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

NLTX is expected to report earnings on 3/18/2024. The consensus EPS estimate for the next earnings is -0.03 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
NLTX revenue by date.NLTX revenue by date.
25M
-100.00%		28.152M190.03M
575.01%		481.85M
153.57%		848.13M
76.02%
EBITDA
YoY % growth
NLTX ebitda by date.NLTX ebitda by date.
N/A
-54.74%		N/A
-33.79%		N/AN/A-39.28M
-69.17%		-61.924M
-45.67%		N/A
3.12%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
NLTX ebit by date.NLTX ebit by date.
-37.65M
-76.43%		-51.12M
-35.78%		-32.62M
36.19%		-84.66M
25.08%		-42.491M
-70.05%		-63.373M
-46.05%		-57.256M
2.64%		-32.761M
44.57%		-36.822M
-12.40%		-36.38M
1.20%		N/AN/AN/AN/AN/A
Operating Margin
NLTX operating margin by date.NLTX operating margin by date.
N/AN/A-130.48%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
NLTX eps by date.NLTX eps by date.
-1.96
-13.29%		-2.14
-9.18%		-1.35
36.92%		-13.46
44.44%		-3.65
-8.00%		-5.73
-171.13%		-5.02
-136.78%		-0.33
93.72%		-0.17
46.87%		-0.64
-268.65%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 23
EPS
Q2Q % growth		-0.03
97.45%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-2.142M
84.97%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NLTX Yearly Revenue VS EstimatesNLTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2027 2028 2029 2030 200M 400M 600M 800M
NLTX Yearly EPS VS EstimatesNLTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2 -4 -6 -8 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.36%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NEOLEUKIN THERAPEUTICS INC / NLTX Forecast FAQ

What is the average price target for NEOLEUKIN THERAPEUTICS INC (NLTX) stock?

6 analysts have analysed NLTX and the average price target is 1.53 USD. This implies a price decrease of -56.16% is expected in the next year compared to the current price of 3.49.

What is the next earnings date for NLTX stock?

NEOLEUKIN THERAPEUTICS INC (NLTX) will report earnings on 2024-03-18, after the market close.

What are the consensus estimates for NEOLEUKIN THERAPEUTICS INC (NLTX) next earnings?

The consensus EPS estimate for the next earnings of NEOLEUKIN THERAPEUTICS INC (NLTX) is -0.03 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for NLTX stock?

The number of analysts covering NEOLEUKIN THERAPEUTICS INC (NLTX) is 6.